Chemotherapy for Advanced Non-Hodgkin's Lymphoma with CVP Therapy
August 1983
in “
PubMed
”
New to Prednisolone? There is a guide in the encyclopedia. Read the guide → Studysummary This study reported that VCP combination chemotherapy achieved a complete response in 53% of advanced non-Hodgkin's lymphoma patients, although more intensive treatment may be needed for improved outcomes.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study involved 31 patients with advanced non-Hodgkin's lymphoma treated with CVP therapy, which included vincristine, cyclophosphamide, and prednisolone. The median age was 56 years, and the majority had diffuse histological types. Out of 28 patients with measurable disease, 53% achieved complete response (CR) and 18% partial response (PR). The median time to CR was 20 days, with a response duration of 14 months. Survival was better for complete responders, with 80% surviving 1 year and 47% surviving 3 years. The treatment's toxicities were mild and included peripheral neuropathy, hair loss, and leukopenia. The study suggested the need for more intensive chemotherapy to improve CR rates and duration.
